Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) reported EBT Margin of 3556.06% for Q3 2024, up 1977077.0% year-over-year from N/an in Q4 2023, and down 21.78% quarter-over-quarter from 2920.08% in Q2 2024.
Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of EBT Margin data on file, last reported at 3556.06% in Q3 2024.
- EBT Margin for Q3 2024 came in at 3556.06%, up 1977077.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 18357.58% (changed N/A YoY), and the FY2024 annual result was 23481.41%, down 1361541.0% from the prior year.
- EBT Margin retreated to 3556.06% in Q3 2024 per ADGM's latest filing, from 2920.08% in the prior quarter.
- Over five years, EBT Margin peaked at 2920.08% in Q2 2024 and troughed at 36800.0% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 27.84% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.84% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 22.61% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.17% |
| 10 | Adagio Medical Holdings | 16.44 Mn | 3.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,556.06% |
| Jun 30, 2024 | -2,920.08% |
| Mar 31, 2024 | -36,800.00% |
| Dec 31, 2023 | -7,575.64% |
| Sep 30, 2023 | -23,326.83% |